BioCentury | Jan 1, 2007
Company News

Intrexon, RheoGene deal

...merge to form Intrexon Corp. The deal combines Intrexon's UltraVector technology for assembling transgenes with RheoGene's...
...recombinase platforms for gene therapy delivery. Intrexon CEO Robert Beech will retain his title, and RheoGene...
...Tom Tillett will become COO. Financial terms were not disclosed. Intrexon Corp. , Blacksburg, Va. RheoGene Inc....
BioCentury | Dec 11, 2006
Company News

RheoGene, J&J deal

...JNJ's Centocor Inc. subsidiary received a non-exclusive license to RheoGene's AttSite recombinase technology, which guides gene...
...recombinase technology, which guides gene insertion to facilitate genetic research. Financial terms were not disclosed. RheoGene Inc....
BioCentury | Dec 5, 2005
Company News

RheoGene, Serologicals deal

...International Inc. (Temecula, Calif.) subsidiary received a semi-exclusive license to commercialize research products that use RheoGene's...
...will use the technology to produce cloning and expression reagents. Financial terms were not disclosed. RheoGene Inc....
BioCentury | Sep 19, 2005
Company News

RheoGene, Xenogen deal

...XGEN's Xenogen Biosciences Corp. subsidiary received a license to use RheoGene's RheoSwitch system to develop and...
...validation. The companies also will collaborate on the controlled delivery and regulation of RNAi expression. RheoGene Inc....
BioCentury | Aug 8, 2005
Company News

RheoGene scientific advisory board update

RheoGene Inc. , Norristown, Penn. Business: Gene/Cell therapy Appointed: Alan Russell as chairman, director of the McGowan Institute for Regenerative Medicine; Fred Gage, a professor at Salk Institute; Richard Gregory, SVP and head of research at...
BioCentury | Aug 1, 2005
Company News

Cellumen, RheoGene deal

...Cellumen will non-exclusively use RheoGene's RheoSwitch inducible gene technology and RheoPlex multigene regulation technology to develop...
...lines for use in Cellumen's systems cell biology profiling assays. Cellumen Inc. , Pittsburgh, Penn. RheoGene Inc....
BioCentury | Apr 25, 2005
Company News

RheoGene, TissueGene deal

...cell therapies for non-union bone fractures, non-healing bone wounds and osteoporosis. The companies will use RheoGene’s...
...regulate the expression of a bone morphogenic protein (BMP) in a TissueGene cell therapy product. RheoGene Inc....
BioCentury | Jul 12, 2004
Strategy

Incubating a Company

...University of Pittsburgh Medical Center (UPMC), with venture stakes in 19 companies. Among those is RheoGene Inc....
...for-profit entities as part of its portfolio. Thus, the decision by UPMC to spin in RheoGene...
...on-off switch," Russell said. "I realized that RheoGene might have what I'd been talking about." RheoGene...
BioCentury | Jun 14, 2004
Company News

New England Biolabs Inc., RheoGene deal

...and distribute research kits and related products based on RheoGene's RheoSwitch inducible gene regulation technology. RheoGene...
...deal is expected to launch by year end. New England Biolabs Inc. , Beverly, Mass. RheoGene Inc....
BioCentury | Feb 23, 2004
Company News

Rohm and Haas Co., University of Pittsburgh Medical Center deal

...its majority-owned subsidiary RheoGene Inc. (Norristown, Penn.), which formerly operated as RHeoGene LLC. Through the donation, RheoGene...
Items per page:
1 - 10 of 18
BioCentury | Jan 1, 2007
Company News

Intrexon, RheoGene deal

...merge to form Intrexon Corp. The deal combines Intrexon's UltraVector technology for assembling transgenes with RheoGene's...
...recombinase platforms for gene therapy delivery. Intrexon CEO Robert Beech will retain his title, and RheoGene...
...Tom Tillett will become COO. Financial terms were not disclosed. Intrexon Corp. , Blacksburg, Va. RheoGene Inc....
BioCentury | Dec 11, 2006
Company News

RheoGene, J&J deal

...JNJ's Centocor Inc. subsidiary received a non-exclusive license to RheoGene's AttSite recombinase technology, which guides gene...
...recombinase technology, which guides gene insertion to facilitate genetic research. Financial terms were not disclosed. RheoGene Inc....
BioCentury | Dec 5, 2005
Company News

RheoGene, Serologicals deal

...International Inc. (Temecula, Calif.) subsidiary received a semi-exclusive license to commercialize research products that use RheoGene's...
...will use the technology to produce cloning and expression reagents. Financial terms were not disclosed. RheoGene Inc....
BioCentury | Sep 19, 2005
Company News

RheoGene, Xenogen deal

...XGEN's Xenogen Biosciences Corp. subsidiary received a license to use RheoGene's RheoSwitch system to develop and...
...validation. The companies also will collaborate on the controlled delivery and regulation of RNAi expression. RheoGene Inc....
BioCentury | Aug 8, 2005
Company News

RheoGene scientific advisory board update

RheoGene Inc. , Norristown, Penn. Business: Gene/Cell therapy Appointed: Alan Russell as chairman, director of the McGowan Institute for Regenerative Medicine; Fred Gage, a professor at Salk Institute; Richard Gregory, SVP and head of research at...
BioCentury | Aug 1, 2005
Company News

Cellumen, RheoGene deal

...Cellumen will non-exclusively use RheoGene's RheoSwitch inducible gene technology and RheoPlex multigene regulation technology to develop...
...lines for use in Cellumen's systems cell biology profiling assays. Cellumen Inc. , Pittsburgh, Penn. RheoGene Inc....
BioCentury | Apr 25, 2005
Company News

RheoGene, TissueGene deal

...cell therapies for non-union bone fractures, non-healing bone wounds and osteoporosis. The companies will use RheoGene’s...
...regulate the expression of a bone morphogenic protein (BMP) in a TissueGene cell therapy product. RheoGene Inc....
BioCentury | Jul 12, 2004
Strategy

Incubating a Company

...University of Pittsburgh Medical Center (UPMC), with venture stakes in 19 companies. Among those is RheoGene Inc....
...for-profit entities as part of its portfolio. Thus, the decision by UPMC to spin in RheoGene...
...on-off switch," Russell said. "I realized that RheoGene might have what I'd been talking about." RheoGene...
BioCentury | Jun 14, 2004
Company News

New England Biolabs Inc., RheoGene deal

...and distribute research kits and related products based on RheoGene's RheoSwitch inducible gene regulation technology. RheoGene...
...deal is expected to launch by year end. New England Biolabs Inc. , Beverly, Mass. RheoGene Inc....
BioCentury | Feb 23, 2004
Company News

Rohm and Haas Co., University of Pittsburgh Medical Center deal

...its majority-owned subsidiary RheoGene Inc. (Norristown, Penn.), which formerly operated as RHeoGene LLC. Through the donation, RheoGene...
Items per page:
1 - 10 of 18